Avid Bioservices Inc (CDMO)
9.96
-0.19
(-1.87%)
USD |
NASDAQ |
Oct 31, 16:00
9.96
0.00 (0.00%)
After-Hours: 20:00
Avid Bioservices Cash from Operations (TTM): 7.508M for July 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
July 31, 2024 | 7.508M |
April 30, 2024 | 10.95M |
January 31, 2024 | 12.84M |
October 31, 2023 | 2.212M |
July 31, 2023 | -7.869M |
April 30, 2023 | -12.72M |
January 31, 2023 | -15.26M |
October 31, 2022 | -3.122M |
July 31, 2022 | 11.32M |
April 30, 2022 | 9.465M |
January 31, 2022 | 26.71M |
October 31, 2021 | 26.71M |
July 31, 2021 | 26.51M |
April 30, 2021 | 31.18M |
January 31, 2021 | 16.37M |
October 31, 2020 | 10.54M |
July 31, 2020 | 6.022M |
April 30, 2020 | 5.827M |
January 31, 2020 | 8.428M |
October 31, 2019 | 5.982M |
July 31, 2019 | -6.615M |
April 30, 2019 | -11.60M |
January 31, 2019 | -15.13M |
October 31, 2018 | -20.68M |
July 31, 2018 | -21.23M |
Date | Value |
---|---|
April 30, 2018 | -25.99M |
January 31, 2018 | -39.65M |
October 31, 2017 | -41.85M |
July 31, 2017 | -33.46M |
April 30, 2017 | -39.17M |
January 31, 2017 | -33.23M |
October 31, 2016 | -29.80M |
July 31, 2016 | -40.28M |
April 30, 2016 | -39.59M |
January 31, 2016 | -36.38M |
October 31, 2015 | -38.44M |
July 31, 2015 | -40.61M |
April 30, 2015 | -36.02M |
January 31, 2015 | -40.12M |
October 31, 2014 | -38.80M |
July 31, 2014 | -32.77M |
April 30, 2014 | -28.25M |
January 31, 2014 | -26.46M |
October 31, 2013 | -24.88M |
July 31, 2013 | -28.95M |
April 30, 2013 | -20.93M |
January 31, 2013 | -24.95M |
October 31, 2012 | -26.88M |
July 31, 2012 | -26.71M |
April 30, 2012 | -35.88M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-15.26M
Minimum
Jan 2023
31.18M
Maximum
Apr 2021
9.139M
Average
9.465M
Median
Apr 2022
Cash from Operations (TTM) Benchmarks
MEI Pharma Inc | -50.47M |
Altimmune Inc | -71.48M |
NovaBay Pharmaceuticals Inc | -3.388M |
Palatin Technologies Inc | -31.46M |
iBio Inc | -18.55M |